August 17, 2023 Comments Off on New patent for United Therap drug REMODULIN Posted in: Patent Added Annual Drug Patent Expirations for REMODULIN Remodulin is a drug marketed by United Therap and is included in two NDAs. It is available from one supplier. There are nine patents…
The post New patent for United Therap drug REMODULIN appeared first on Dr…
August 17, 2023 Comments Off on New patent for United Therap drug TYVASO DPI Posted in: Patent Added Annual Drug Patent Expirations for TYVASO+DPI Tyvaso Dpi is a drug marketed by United Therap and is included in one NDA. It is available from one supplier. There are six…
The post New patent for United Therap drug TYVASO DPI appeared first on DrugPaten…
